Category: Business

OcuSciences Announces Publication Showing Flavoprotein Fluorescence May Detect Improvement in Metabolic Function Preceding Structural Improvement in Patients with Diabetic Macular Edema Treated with Anti-VEGF

ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, Inc., a clinical-stage biotechnology company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the online publication of its diabetic macular edem…

The Global Market for Ophthalmic Lasers (2018-2023) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Laser Market – Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Ophthalmic Laser market is projected to grow at a CAGR of 6.09% to reach US$706.588 million by 2023, from US$495.529 million in 2017. Growing prevalence of ophthalmic diseases like glaucoma, cataract and other vision related issues and increasing initiatives by the government to control visual impairment are expected to drive the growth of the mark

Ophthalmics – Global Partnering Report (2012-2018): Updated Deal Trends, Players and Financials – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics Partnering 2012 to 2018 provides the full collection of Ophthalmics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2012. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology.

Intraocular Lens Market – Global Forecasts from 2018 to 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market – Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Intraocular lens market is projected to grow at a CAGR of 5.98% to reach US$14.759 billion by 2023, from US$10.416 billion in 2017. Growing prevalence of eye diseases like cataracts and increase in initiatives taken by the government to eliminate avoidable blindness are expected to fuel the growth of the intraocular lens market. According to World

Ophthalmology Disease & Epidemiology Overview 2018 Featuring Alimera Sciences, Allergan, Regeneron, Bayer, Santen, Roche, Genentech, & Novartis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmology – Disease & Epidemiology Overview” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering. This report provides a disease market overview for each indication and global epidemiology overviews for each indication. The Ophthalmology Disease & Epidemiology Overview report provides disease market overviews and global epidemiology overviews for 4 indications in the Ophthalmology therapy area: Diabetic Macular Edema

Retinopathy of Prematurity – 2018 Pipeline Insight Featuring Biomar Microbial Technologies, F. Hoffmann-La Roche, Recordati, Radikal Therapeutics, EyeGene, and Insmed – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Retinopathy of Prematurity – Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Retinopathy of Prematurity development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by development